Dabrafenib inhibits the growth of BRAF-WT cancers through CDK16 and NEK9 inhibition (Q47096483)

From Wikidata
Jump to navigation Jump to search
scientific article published on 7 November 2017
edit
Language Label Description Also known as
English
Dabrafenib inhibits the growth of BRAF-WT cancers through CDK16 and NEK9 inhibition
scientific article published on 7 November 2017

    Statements

    Dabrafenib inhibits the growth of BRAF-WT cancers through CDK16 and NEK9 inhibition (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit